In one recent study, a pseudovirus-based neutralization assay (PBNA) was developed to evaluate the neutralization of certain antibodies against SARS-CoV-2. Briefly, ...

The traditional gold standards such as live virus neutralization and cellular pseudovirus neutralization assays for measuring SARS-CoV-2 nAbs are tedious and laborious.

The incredible efforts of scientists and public health agencies worldwide in response to SARS-CoV-2 has resulted in the emergency use authorization and rapid deployment of antibody-based ...

Nearly all participants had detectable activity in a pseudovirus neutralization assay, 2 with 50% inhibitory dilution (ID 50) GMTs of 80 (95% CI, 40 to 135), 57 (95% CI, 30 to 106), and 59 (95% CI ...

Panel B shows neutralizing antibody titers by a luciferase-based pseudovirus neutralization assay in 19 participants who were recently infected with the BA.1 or BA.2 subvariant.

Development of serological assays to detect SARS-CoV-2 antibodies ... Neutralization assays, which determine whether an individual has neutralizing antibodies and is therefore immunized against ...

The neutralization assay with infectious SARS-CoV-2 is more complicated to implement as the virus needs to be handled in a BSL3 laboratory. It uses a fixed dose of the virus which destroys 100% of ...

--Beroni Group, an Australia- based diversified biopharmaceutical enterprise, today announces successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript ...

The incredible efforts of scientists and public health agencies worldwide in response to SARS-CoV-2 has resulted in the emergency use authorization and rapid deployment of antibody-based ...

NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical ...

NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical ...